High- and Low-risk Actinic Keratosis Referrals to Secondary Care

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

3379 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-01

Study Completion Date

2025-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the implementation of the General Practitioners guidelines 'Suspicious Skin Lesions' and investigated whether their publication and implementation has led to a reduction in the proportion of referrals of low-risk patients with actinic keratosis to secondary care, after publication of the General Practitioners guidelines and implementation activities.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Implementation of Actinic Keratosis Guideline Among General Practitioners.

NCT05976048

Actinic Keratoses

ACTIVE_NOT_RECRUITING

The Influence of an E-learning Program on Recognition of Actinic Keratosis

NCT05987553

Actinic Keratoses E-learning Dermatology

ACTIVE_NOT_RECRUITING

Patient Decision Aid for the Treatment of Actinic Keratosis

NCT06008171

Actinic Keratoses Patient Decision Aid

ACTIVE_NOT_RECRUITING NA

Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis

NCT01656226

Actinic Keratosis

UNKNOWN PHASE4

Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.

NCT01806961

Actinic Keratosis

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the Dutch healthcare system, patients are first examined by the general practitioner who decides whether a referral to a dermatologist is indicated. Both general practitioners and dermatologists can diagnose and treat patients with actinic keratosis. Therefore, it is necessary to distinguish which patients the general practitioner should refer to a dermatologist and which patients are suitable to be treated by the general practitioner.

This retrospective data study evaluates the proportion of low risk actinic keratosis patients in 2019 en 2018.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Actinic Keratoses

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low risk patients

Low risk actinic keratosis patients referred by the general practitioner and diagnosed as actinic keratosis by the dermatologist in 2018 and 2019.

No interventions assigned to this group

High risk patients

High risk actinic keratosis patients referred by the general practitioner and diagnosed as actinic keratosis by the dermatologist in 2018 and 2019.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients of 18 years and older
* referred to dermatologist for suspicion of actinic keratosis and diagnosed as actinic keratosis by the dermatologist
* treated at MaastrichtUMC+ or TergooiHospital

Exclusion Criteria

* different diagnosis than actinic keratosis
* referred by a different specialist than the general practitioner
* referred with multiple problems
* referred for a second opinion
* if the patients was treated as different diagnosis than actinic keratosis by general practitioner

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No